These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 35763229

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR+/HER2- Breast Cancer in the Post-RxPONDER Era?
    Pilewskie M, Sevilimedu V, Eroglu I, Le T, Wang R, Morrow M, Braunstein LZ.
    Ann Surg Oncol; 2022 Oct; 29(10):6267-6273. PubMed ID: 35849294
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts.
    Weiss A, Martínez-Sáez O, Waks AG, Laws A, McGrath M, Tarantino P, Portnow L, Winer E, Rey M, Tapia M, Prat A, Partridge AH, Tolaney SM, Cejalvo JM, Mittendorf EA, King TA.
    Cancer; 2023 Jun 15; 129(12):1836-1845. PubMed ID: 36951169
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?
    Williams AD, Ruth K, Shaikh SS, Vasigh M, Pronovost MT, Aggon AA, Porpiglia AS, Bleicher RJ.
    Cancer; 2024 Apr 01; 130(7):1052-1060. PubMed ID: 38018862
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
    Fan YJ, Li JC, Zhu DM, Zhu HL, Zhao Y, Zhu XB, Wu G, Bai TT.
    BMC Surg; 2023 Jul 26; 23(1):209. PubMed ID: 37495945
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal.
    Cebrecos I, Mension E, Alonso I, Castillo H, Sanfeliu E, Vidal-Sicart S, Ganau S, Vidal M, Schettini F.
    Ann Surg Oncol; 2023 Aug 26; 30(8):4657-4668. PubMed ID: 36809608
    [Abstract] [Full Text] [Related]

  • 12. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis.
    Petousis S, Christidis P, Margioula-Siarkou C, Liberis A, Vavoulidis E, Margioula-Siarkou G, Vatopoulou A, Papanikolaou A, Mavromatidis G, Dinas K.
    Arch Gynecol Obstet; 2022 Oct 26; 306(4):1221-1234. PubMed ID: 35249123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patterns of completion axillary dissection for patients with cT1-2N0 breast cancer undergoing total mastectomy with positive sentinel lymph nodes.
    Schwieger L, Postlewait LM, Subhedar PD, Geng F, Liu Y, Gillespie T, Arciero CA.
    J Surg Oncol; 2024 Mar 26; 129(3):468-480. PubMed ID: 37955191
    [Abstract] [Full Text] [Related]

  • 17. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP, Hoskin TL, Day CN, Sanders SB, Boughey JC.
    Ann Surg Oncol; 2022 Aug 26; 29(8):4740-4749. PubMed ID: 35451727
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer.
    Noguchi M, Inokuchi M, Yokoi-Noguchi M, Morioka E.
    Breast Cancer; 2022 Mar 26; 29(2):209-215. PubMed ID: 34591289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.